Dr David Montgomery has been appointed executive director of research at Prostate Cancer UK.
Dr Montgomery brings extensive experience to the leading men’s health charity, as he is initially trained as a surgeon, where he spent a period of time in breast cancer research before moving to the pharmaceutical industry in 2008, where his focus remained in oncology.
He spent seven years as UK medical director at Pfizer, before being appointed vice president of their Global Science Exchange group and also chaired the oncology medical directors’ forum at the Association of the British Pharmaceutical Industry (ABPI).
Dr Montgomery said: “It’s a real honour to be appointed to such a fantastic charity. 1 in 8 men in the UK will get prostate cancer in their lifetime, and I’m excited to have the opportunity to use my experience both in medicine and the pharmaceutical industry to help make a real difference for these men.
“Prostate Cancer UK has an outstanding record when it comes to research and one of my key aims is to help drive the charity forward as it continues to take research from the lab, through trials and into clinics as soon as possible.”
